179 related articles for article (PubMed ID: 3981465)
21. Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus.
Kursar JD; Nelson DL; Wainscott DB; Cohen ML; Baez M
Mol Pharmacol; 1992 Oct; 42(4):549-57. PubMed ID: 1331748
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the receptors involved in the 5-HT-induced excitation of canine antral longitudinal muscle.
Prins NH; Akkermans LM; Lefebvre RA; Schuurkes JA
Br J Pharmacol; 2001 Nov; 134(6):1351-9. PubMed ID: 11704657
[TBL] [Abstract][Full Text] [Related]
23. Smooth muscle 5-HT2A receptors mediating contraction of porcine isolated proximal stomach strips.
Janssen P; Prins NH; Meulemans AL; Lefebvre RA
Br J Pharmacol; 2002 Dec; 137(8):1217-24. PubMed ID: 12466231
[TBL] [Abstract][Full Text] [Related]
24. Motor response secondary to the release of endogenous serotonin by tryptamine in guinea-pig ileal longitudinal muscle with adherent myenteric plexus.
Takaki M; Mizutani M; Nakayama S
Arch Int Pharmacodyn Ther; 1988; 291():132-41. PubMed ID: 3365058
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of 5-Hydroxytryptamine-receptor subtypes in circular muscle from the rat stomach.
Komada T; Yano S
Biol Pharm Bull; 2007 Mar; 30(3):508-13. PubMed ID: 17329847
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.
Prins NH; Briejer MR; Schuurkes JA
Br J Pharmacol; 1997 Feb; 120(4):714-20. PubMed ID: 9051313
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of 5-hydroxytryptamine on rat stomach fundus: mediated indirectly by activation of noradrenaline release.
Béjar E; Malone MH
J Pharm Pharmacol; 1995 Aug; 47(8):637-42. PubMed ID: 8583363
[TBL] [Abstract][Full Text] [Related]
28. Differential inhibition of 5-hydroxytryptamine (5-HT) mediated contraction of rat thoracic aortae by phentolamine and tolazoline: correlation with inhibition of 5-HT binding and calcium ion.
Curro FA; Greenberg S
Methods Find Exp Clin Pharmacol; 1983; 5(2):107-20. PubMed ID: 6876942
[TBL] [Abstract][Full Text] [Related]
29. Comparison of contractions to serotonin, carbamylcholine and prostaglandin F2 alpha in rat stomach fundus.
Secrest RJ; Schoepp DD; Cohen ML
J Pharmacol Exp Ther; 1989 Sep; 250(3):971-8. PubMed ID: 2550624
[TBL] [Abstract][Full Text] [Related]
30. Agonist potencies of tryptamine derivatives at pre- and postjunctional receptors in canine saphenous vein.
Müller-Schweinitzer E
Postgrad Med J; 1981; 57 Suppl 1():36-44. PubMed ID: 7301710
[TBL] [Abstract][Full Text] [Related]
31. Serotonin-stimulated phosphoinositide turnover: mediation by the S2 binding site in rat cerebral cortex but not in subcortical regions.
Conn PJ; Sanders-Bush E
J Pharmacol Exp Ther; 1985 Jul; 234(1):195-203. PubMed ID: 2989504
[TBL] [Abstract][Full Text] [Related]
32. The 5-hydroxytryptamine2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertensive rats.
Watts SW; Baez M; Webb RC
J Pharmacol Exp Ther; 1996 May; 277(2):1103-13. PubMed ID: 8627522
[TBL] [Abstract][Full Text] [Related]
33. Antiserotonin activity of 9-methyl-2-[3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro -beta-carbolin-1-one (B-193).
Wiczyńska B; Chojnacka-Wójcik E; Rokosz-Pelc A; Mazela H; Przegaliński E
Pol J Pharmacol Pharm; 1989; 41(2):169-81. PubMed ID: 2556691
[TBL] [Abstract][Full Text] [Related]
34. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling.
McKune CM; Watts SW
J Pharmacol Exp Ther; 2001 Apr; 297(1):88-95. PubMed ID: 11259531
[TBL] [Abstract][Full Text] [Related]
36. Comparison of serotonin agonistic and antagonistic activities of a new antidepressant agent Trelibet (EGYT-475) and its metabolite EGYT-2760 on isolated rat fundus.
Malomvölgyi B; Tóthfalusi L; Tekes K; Magyar K
Acta Physiol Hung; 1991; 78(3):201-9. PubMed ID: 1814162
[TBL] [Abstract][Full Text] [Related]
37. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein.
Cohen ML; Schenck K
J Pharmacol Exp Ther; 1999 Sep; 290(3):935-9. PubMed ID: 10454462
[TBL] [Abstract][Full Text] [Related]
38. Receptors involved in the action of 5-HT and tryptamine on the isolated rat stomach fundus preparation.
Frankhuijzen AL; Bonta IL
Eur J Pharmacol; 1974 May; 26(2):220-30. PubMed ID: 4854042
[No Abstract] [Full Text] [Related]
39. Serotonin receptor binding affinities of tryptamine analogues.
Glennon RA; Gessner PK
J Med Chem; 1979 Apr; 22(4):428-32. PubMed ID: 430481
[TBL] [Abstract][Full Text] [Related]
40. 5-HT-mediated myoclonus in the guinea pig as a model of brainstem 5-HT and tryptamine receptor action.
Luscombe G; Jenner P; Marsden CD
Adv Neurol; 1986; 43():529-43. PubMed ID: 2418649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
